SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Merck
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
1580 80 0 MRK
Emcee:  Alfred W. Post Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
105 Jim: I agree, Warner Lambert's Atorvastatin "Turbo Statin" shoulBruce Russell-2/25/1997
104 David: Sure 120 is possible. IMO not probable. Short term, I'd be real hJim Garrison-2/25/1997
103 Bruce: Theres no doubt about the quality of the company and its propects, safetJim Garrison-2/25/1997
102 The combination of in line growth drugs and mature drugs is terrific out to 200Bruce Russell-2/24/1997
101 I too am disappointed with Ligand thus far but it is way to early to through inVector1-2/24/1997
100 Jim, I think 120 is a possibility for MRK. But I wouldn't be disppointed tDavid L. Hachey-2/24/1997
99 Vector1, I see your name in several discussion groups I follow. It seems we haDavid L. Hachey-2/24/1997
98 Jim, I agree with you: with a P/E of 30x and dividend yield of less than 2%, MRJohn Sladek-2/24/1997
97 David: My crystal ball is more like yours. I predict it will have a lot of troJim Garrison-2/24/1997
96 MRK is a such a great company you almost have to look at expected long term retVector1-2/24/1997
95 Price will ultimately be determined by earnings and premiums that go with qualipragat-2/23/1997
94 Jim, I wouldn't bet on it just yet. The current P/E is about 30 which is aDavid L. Hachey-2/23/1997
93 Excellent article... I think Merck is going to keep finding new drugs like FosaDuane Sieren-2/23/1997
92 Update on blockbuster drug: FOSAMAX biz.yahoo.compragat-2/20/1997
91 David, Like my broker at Paine Webber said today, you don't need a stock aCharles Holewinski-2/18/1997
90 That's how I feel about paying the $5 service charge every time I send moneDuane Sieren-2/18/1997
89 Recently saw guest analyst on CNBC (I forgot to write down his name), who was pDAVID BROWN-2/17/1997
88 James, At your age you should not care when to buy a stock like Merck. Just bCharles Holewinski-2/17/1997
87 Mercker. VIMRx has a website at www.vimrx.com. Some interesting information. Todd King-2/16/1997
86 Thanks for your affidavit. You know there are only two opinions: this and the wAlfred W. Post-2/16/1997
85 Hi Mike and thank you very much for your input. Looking forewqrd to the next maAlfred W. Post-2/16/1997
84 Hear's two Merck related drug companies you might want to research. RegenerMike Mercker-2/16/1997
83 Gary I'll second Alfred"s answer. I wouldn't try to time the markeMike Mercker-2/16/1997
82 I kept thinking that SEARS would buy them out.... The parking lot is always fulDuane Sieren-2/15/1997
81 You may well be correct. I have not done any real research on how many companiduncan moyer-2/15/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News